Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
4
×
boston blog main
clinical trials
life sciences
national blog main
boston top stories
fda
deals
dyne therapeutics
investing
myotonic dystrophy type 1
rare disease drugs
san diego blog main
san francisco blog main
480 biomedical
akouos
arsenal medical
astellas pharma
astellas pharmaceuticals
atlas venture
audentes therapeutics
avidity biosciences
biotech ipos
bluebird bio
bob langer
california institute for biomedical research
chronic rhinosinusitis
covid-19
decibel therapeutics
drug delivery
duchenne muscular dystrophy
facioscapulohumeral muscular dystrophy
frequency therapeutics
gene therapy
genzyme
george whitesides
harvard university
hearing loss
inflammation
What
ipo
4
×
therapeutics
4
×
developing
drug
medicines
company
dyne
genetic
million
muscle
raised
rare
treat
affects
ago
americans
approved
biotech
biotechs
brings
considering
data
date
debut
diseases
disorders
dyne’s
early
expected
experimental
eyes
fda
frequency
having
hearing
humans
ipos
late
long
loss
Language
unset
Current search:
therapeutics
×
ipo
×
boston
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds